Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...